BiochemistrybioRxiv
Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as PfCDPK1 kinase inhibitors
I. Irfan, A. Uddin, R. Jain…·S. Singh
This study evaluates novel CQTrICh-analogs as antimalarials, showing they inhibit Plasmodium falciparum strains and target PfCDPK1 kinase with selectivity over human kinases.
DOI 10.1016/j.heliyon.2024.e25077